−43.39USD
−6.04 MUSD
1.05 M
About Synaptogenix, Inc.
Sector
CEO
Alan J. Tuchman
Headquarters
New York
Website
Employees (FY)
8
Founded
2012
ISIN
US87167T3005
FIGI
BBG00YG4Q0S0
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SNPX is 4.33 USD — it has decreased by 7.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Synaptogenix, Inc. stocks are traded under the ticker SNPX.
Synaptogenix, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SNPX stock is 10.77% volatile and has beta coefficient of 2.16. Check out the list of the most volatile stocks — is Synaptogenix, Inc. there?
SNPX earnings for the last quarter are −13.50 USD per share, whereas the estimation was −12.00 USD resulting in a −12.50% surprise. The estimated earnings for the next quarter are −13.75 USD per share. See more details about Synaptogenix, Inc. earnings.
Yes, you can track Synaptogenix, Inc. financials in yearly and quarterly reports right on TradingView.
SNPX stock has fallen by 10.35% compared to the previous week, the month change is a 19.44% fall, over the last year Synaptogenix, Inc. has showed a 81.17% decrease.
SNPX net income for the last quarter is −995.97 K USD, while the quarter before that showed 763.20 K USD of net income which accounts for −230.50% change. Track more Synaptogenix, Inc. financial stats to get the full picture.
Today Synaptogenix, Inc. has the market capitalization of 5.06 M, it has increased by 17.24% over the last week.
No, SNPX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SNPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Synaptogenix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 8.00 employees. See our rating of the largest employees — is Synaptogenix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Synaptogenix, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Synaptogenix, Inc. stock shows the sell signal. See more of Synaptogenix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.